The company report, ownership structure, certificate of incorporation, and with the financial statement, if submitted, reveal that NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY, registered under Business ID (TIN) 0301340063, operates from Lot I - 5C, High Tech Park, Tang Nhon Phu A Ward, Thu Duc City, Ho Chi Minh City, Vietnam. Commencing operations on 03 Sep 1997, the company specializes in manufacture of feeds for cattle, poultry and aquatic animals, providing a wide array of products and services. With a charter capital of VND 806,250,000,000, NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY is adequately funded to sustain its business activities. Strategic direction is overseen by HO N, who plays a pivotal role in shaping company policies.
To gain comprehensive insights into NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY, Vanguard Business Information offers detailed business intelligence reports. Our suite of reports includes:
1. Basic Company Report of NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY: Highlights core competencies, operational focus, and fundamental aspects.
2.Comprehensive Company Report of NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY: Provides in-depth analysis, featuring credit reports, financial statement if any, essential business information, and industry trends.
Our expert analysts deliver valuable insights into NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY's market potential and future prospects. The report also includes detailed profiles of key business leaders, offering a holistic view of the company's management structure and leadership dynamics. Whether you're an investor, commercial partner, or competitor, our data-driven analysis empowers informed decision-making in today's competitive business environment.